Daily Cannabis Use Surpasses Alcohol, Cigarettes in Federal Survey

Survey Marks Historic Consumption Milestone

Daily cannabis use now exceeds daily alcohol and tobacco use among U.S. adults, the first time federal data has recorded this crossover. The data, drawn from the National Survey on Drug Use and Health (NSDUH), shows approximately 17.8 million Americans reported using cannabis daily or near-daily in 2025, compared to 14.7 million daily drinkers and 13.9 million daily cigarette smokers.

The milestone reflects two decades of accelerating legalization. As of July 2026, 24 states plus the District of Columbia have enacted adult-use programs, and 38 states permit medical cannabis. Daily-use prevalence has climbed steadily since 2015, when fewer than 8 million Americans reported daily consumption.

Alcohol and Tobacco Decline While Cannabis Rises

Daily drinking rates fell 22% over the past decade, while daily smoking dropped 41%, even as daily cannabis use more than doubled. Public-health researchers attribute the divergence to shifting cultural norms, harm-reduction messaging, and the proliferation of legal retail channels that destigmatize cannabis.

Daily alcohol use peaked in 2012 at 18.9 million adults. Daily cigarette smoking, once the dominant daily-use substance, has declined every year since 2005, when 29.4 million Americans smoked daily. Cannabis overtook cigarettes in daily-use prevalence in 2024. It surpassed alcohol in 2025.

Investor Implications for MSOs and CPG

The consumption shift strengthens the bull case for multi-state operators (MSOs) and signals potential headwinds for alcohol and tobacco incumbents. Daily users drive the majority of cannabis revenue. Industry estimates place daily and near-daily consumers at 70–75% of total sales despite representing fewer than 20% of all past-month users.

MSOs including Curaleaf (CURLF), Trulieve (TCNNF), and Green Thumb Industries (GTBIF) have built loyalty programs and subscription models targeting daily consumers. Analysts at Viridian Capital Advisors estimate that a 10% increase in daily-use prevalence translates to roughly $2.4 billion in incremental annual U.S. cannabis sales, assuming current per-capita spending holds.

Demographic Breakdown: Who Uses Daily

Daily cannabis use is most prevalent among adults aged 26–34, with 8.2% reporting daily or near-daily consumption. The survey data show:

• Ages 18–25: 6.9% daily use
• Ages 26–34: 8.2% daily use
• Ages 35–49: 5.1% daily use
• Ages 50+: 2.3% daily use

Men report daily use at nearly twice the rate of women (6.8% vs. 3.5%). Regionally, daily use is highest in the West (7.1%) and lowest in the South (3.9%), reflecting the concentration of legal markets in Western states.

Public-Health Debate Intensifies

The consumption milestone has reignited debate over daily-use risks, particularly around cannabis-use disorder and mental-health outcomes. Federal researchers note that daily or near-daily use is associated with higher rates of cannabis-use disorder, which affects an estimated 16% of daily users compared to 4% of occasional users.

Critics of legalization point to the data as evidence that expanded access drives problematic use. Advocates counter that cannabis remains far less harmful than alcohol or tobacco by nearly every mortality and morbidity metric, and that legal markets enable better product testing, labeling, and consumer education than prohibition.

Federal Rescheduling Context

The survey results arrive as the DEA finalizes its review of a proposal to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act. If enacted, rescheduling wouldn't legalize cannabis federally but would eliminate the Section 280E tax burden on state-licensed operators, potentially lowering retail prices and further accelerating consumption.

Administrative-law judge hearings on rescheduling are scheduled to conclude in September 2026, with a final rule expected by year-end. Industry analysts estimate that 280E relief could reduce effective tax rates for MSOs from 70–75% to 25–30%, freeing capital for price competition and marketing.

What Operators Are Watching

MSOs and ancillary firms are monitoring whether the daily-use trend plateaus or accelerates as new states come online. Ohio and Pennsylvania are expected to launch adult-use sales in 2027, adding a combined 23 million residents to legal markets. Florida's adult-use ballot measure, if it qualifies for November 2026, would represent the largest single-state expansion to date.

For context on how consumption patterns shape market growth, see the CannIntel topic hub on Cannabis Consumption Trends.

Equity analysts are also watching for potential federal restrictions on marketing or potency caps, which some lawmakers have proposed in response to rising daily-use rates. No such legislation has advanced in the current Congress. Still, the survey data will likely fuel renewed calls for guardrails.